Bremelanotide (PT-141) is a compounded prescription nasal option that acts on melanocortin receptors (our desire pathways) in the brain to help support sexual desire
doi: 10.1016/S2213-2600(15)00043-0, 4
When studied together in laboratory research, the CJC-1295 No DAC + Ipamorelin research peptide combination allows scientists to examine how simultaneous receptor activation influences hormone signaling patterns
While GLP-1 primarily supports appetite control, GIP enhances insulin sensitivity, improves how the body utilizes energy, and supports healthier fat metabolism
According to the study, researchers analyzed electronic health records from nearly 40,000 adults with type 2 diabetes who started GLP-1 receptor agonists, SGLT-2 inhibitors, or DPP-4 inhibitors between 2019 and 2024